Physician Wealth Advisors’s Avidity Biosciences RNAM Stock Holding History

Physician Wealth Advisors’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4	Closed	-$289	–	2210
2025 Q4	$289	Buy	+4	New	+$258	﹤0.01%	1984

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Physician Wealth Advisors's RNAM Position: Q1 2026 in Review

Physician Wealth Advisors sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 4 shares — an estimated $289 sold.

Physician Wealth Advisors first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $289 in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Physician Wealth Advisors reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Physician Wealth Advisors sold 4 Avidity Biosciences shares in Q1 2026, an estimated $289.
Physician Wealth Advisors first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
Physician Wealth Advisors's Avidity Biosciences position peaked at $289 in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Physician Wealth Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.